FindTrial
Sign In

Role of Homoeopathic Medicine in the treatment of Primary Hypothyroidism

Role of Individualised Homoeopathic Medicine in the Treatment of Primary hypothyroidism: an open label, single arm study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097199
Enrollment
46
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine: Detailed and thorough case taking of the patient will be done in accordance with the case taking proforma. All patients will be prescribed Individu
dosage and repetition depend upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing their teeth with
16 doses to be marked on the vial
each dose Dispensary of 5 ml to be taken after 10 uniformly forceful downward strokes (from ear lobule to umbilicus which ends in a jerk) to the vial in 45 ml normal water in a clean cup, to stir well

Sponsors

Dr Bidhan Mistry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years. 2. Patients of both sexes. 3. Patient with serum TSH level greater than 4 mIU/L and FT4 level lesser than 0.8ng/dL 4. Fresh cases or patients who have not received treatment for hypothyroidism in the last three months. 5. Patient presenting with symptoms of primary hypothyroidism. 6. Patients agree to undergo some investigation, if required. 7. Patients willing to give written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient with serum TSH level lesser than 4mIU/L and FT4 level greater than 0.8 ng/dL. 2. Patients take any other treatment for primary hypothyroidism from other system of medicine. 3. Patient having any uncontrolled systemic illness or any life-threatening disease. 4. Patient not willing to participate in the study. 5. Patients who do not undergo regular follow up or not willing to undergo further treatment for personal reasons. 6. Pregnant or lactating mothers. 7. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other forms of substance abuse and/or dependence. 8. Already been in homoeopathic treatment for any chronic illness for the last 6 months. 9. Simultaneous participation in any other clinical trial. 10. Patients not willing to undergo any investigation, if so advised.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be assessed by measuring serum TSH and FT4 levels at baseline and after 6 months, at the end of the studyTimepoint: baseline, after 6 months of intervention—

Secondary

MeasureTime frame
Quality of Life Questionnaire (ThyPRO-39)Timepoint: baseline, and after 6 months of intervention—

Countries

India

Contacts

Public ContactDr Rupali Bhaduri

The Calcutta Homoeopathic Medical College and Hospital

drrupalibhaduri@gmail.com9571806989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026